Case report: Visceral leishmaniasis in a patient with Wegener's granulomatosis [3]

Rheumatology

Volumn 43, Issue 7, 2004, Pages 935-937

  Sollima, Salvatore ^a   Corbellino, M ^a   Piolini, R ^a   Calattini, S ^a   Imparato, S ^a   Antinori, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; PROTOZOAL DNA; AMPHOTERICIN B; ANTIPROTOZOAL AGENT;

AGED; BONE MARROW BIOPSY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FOLLOW UP; HERPES; HUMAN; LABORATORY DIAGNOSIS; LEISHMANIA; LETTER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VISCERAL LEISHMANIASIS; WEGENER GRANULOMATOSIS; ANIMAL; LEISHMANIA INFANTUM; PARASITOLOGY;

AGED; AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; WEGENER GRANULOMATOSIS;

EID: 3242878825     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh220     Document Type: Letter

References (10)

1. Guerin PJ, Olliaro P, Sundar S et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002;2:494-501.
2. Fernandez-Guerrero ML, Aguado JM, Buzon L et al. Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987;83:1098-102.
3. World Health Organization. Leishmania/HIV co-infection, south-western Europe, 1990-1998. Retrospective analysis of 965 cases. Wkly Epidemiol Rec 1999;74:365-76.
4. Berenguer J, Gomez-Campdera F, Padilla B et al. Visceral leishmaniasis (Kala-azar) in transplant recipients. Transplantation 1998;65:1401-4.
5. Scatena P, Messina F, Gori S et al. Visceral leishmaniasis in a patient treated for polyarteritis nodosa. Clin Exp Rheumatol 2003;21(Suppl 32):S121-S123.
6. Rosenthal E, Marty P, del Giudice P et al. HIV and leishmania coinfection: a review of 91 cases with focus on atypical locations of leishmania. Clin Infect Dis 2000;31:1093-5.
7. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
8. Sneller MC. Wegener's granulomatosis. J Am Med Assoc 1995;273:1288-91.
9. Carruthers DM, Watts RA, Symmons DP, Scott DG. Wegener's granulomatosis: increased incidence or increased recognition? Br J Rheumatol 1996;35:142-5.
10. Pizzuto M, Piazza M, Senese D et al. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol 2001;39:357-61.